• MindMaze Therapeutics signed definitive channel partnership agreement with Vibra Healthcare to scale its FDA-cleared digital neurotherapeutics neurorehabilitation platform across U.S. health systems.
• Vibra will act as strategic commercial partner, leveraging national provider relationships to drive adoption.
• Commercial model draws on Vibra’s two-year, multi-site deployment across five inpatient rehabilitation centers, which it said enabled higher-intensity therapy at scale without adding staffing burden.
• MindMaze expects partnership to be key driver of new U.S. health system customer wins in second half of 2026 and beyond.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MindMaze Therapeutics Holding SA published the original content used to generate this news brief on May 12, 2026, and is solely responsible for the information contained therein.